Podiatry

In part one of this interview on the use of amniotic membrane as a possible treatment for diabetic ulcers, Diabetes in Control publisher first talks with Dr. Don Fetterolf about the prevalence of diabetic foot ulcers, the impact of the condition and the groups who are affected.

Topical spray shows significant slough reduction and rapid wound healing.

Female, 32 years of age, type 1 diabetes, presented with Stage II partial thickness ulcer between 1st and 2nd toe R foot, and several Stage I areas on both feet. She had recently traveled and had bought several pair of new shoes for her trip.

Study cites vascular, nonvascular causes…. The purpose of this study was to assess the odds of all-cause mortality in individuals with diabetic foot ulceration (DFU) compared with those with diabetes and no history of DFU. In addition, we sought to determine the strength of association of DFU with cardiovascular and …

Two weeks ago, a patient came in to the pharmacy complaining that his feet were burning and sore, and he was developing blisters on the top of his left foot. The patient had diabetes for about 13 years and had recently been running an A1c of 7.9. He was also …

The difference between low and high ankle-brachial index can be indicator for diabetic retinopathy… Patients with diabetes are at a greater risk for peripheral artery disease caused by atherosclerosis. Previous studies showed that many diabetic patients who received an amputation had peripheral artery disease. The ankle-brachial index is used as …

Study finds affected patients at increased risk of CVD, chronic kidney disease and death… Diabetes patients with lower extremity amputation are more likely to die from other complications such as cardiovascular disease (CVD) and chronic kidney disease, and to have more lower extremity amputation (LEA) than other diseases. The purpose …

Study finds higher mortality incidence in telemedical monitoring group compared with standard outpatient-monitoring group… Telemonitoring of diabetic foot ulcers involves remotely monitoring patients who are not at the same location as the health care provider. Patients communicate with a specialized ulcer nurse or physician at an outpatient clinic through telephone …

This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …

This week we are excited about our exclusive interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell and her team have been doing some groundbreaking work on battling chronic wounds using placental biomaterials. Steve Freed:  Welcome, Dr. Janice Smiell. Let’s begin by having you tell us a …